Related Experiment Video
Updated: May 20, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Cardiac autophagy: good with the bad
1Department of Internal Medicine (Cardiology), University of Texas Southwestern Medical Center, Dallas, TX, USA.
Insights
Pathological cardiac hypertrophy, a key factor in heart failure, may be treatable by targeting cardiomyocyte autophagy. Further research is needed to understand the complex adaptive and maladaptive roles of autophagy in cardiac stress responses.
Area of Science:
- Cardiovascular Biology
- Cellular Stress Response
- Molecular Cardiology
Background:
- Stress-induced cardiac hypertrophy is a critical step in heart failure progression.
- Cardiomyocyte autophagy is being explored as a therapeutic target to control pathological cardiac hypertrophy.
- Current understanding of the molecular mechanisms governing cardiomyocyte autophagy, particularly its adaptive and maladaptive roles, remains incomplete.
Purpose of the Study:
- To investigate the role of cardiomyocyte autophagy in pathological cardiac hypertrophy.
- To elucidate the mechanisms underlying the adaptive and maladaptive features of autophagy in the stressed myocardium.
- To assess the potential of targeting cardiomyocyte autophagy for therapeutic intervention in heart failure.
Main Methods:
- Review of existing literature on cardiac hypertrophy and autophagy.
- Analysis of molecular pathways involved in cardiomyocyte stress response.
- Exploration of potential therapeutic strategies targeting autophagy.
Main Results:
- Cardiomyocyte autophagy plays a complex role in the cardiac response to stress.
- The adaptive and maladaptive mechanisms of autophagy in hypertrophy are not fully understood.
- Suppression of pathological cardiac hypertrophy via autophagy modulation is a potential therapeutic avenue.
Conclusions:
- Cardiomyocyte autophagy is a promising, yet complex, target for managing stress-induced cardiac hypertrophy.
- Further research is essential to unravel the intricacies of autophagy's dual role (adaptive vs. maladaptive) in cardiac remodeling.
- Understanding these mechanisms could lead to novel therapeutic strategies for heart failure.
Abstract:
Stress-induced hypertrophic growth of the myocardium is a pathogenetic milestone in the progression of heart failure. Some evidence suggests that suppression of pathological cardiac hypertrophy per se is a viable target for therapeutic intervention, and cardiomyocyte autophagy is an attractive mechanism for consideration as a means of controlling the hypertrophic response. However, although considerable insights have been gleaned in the molecular mechanisms governing cardiomyocyte autophagy, many details critical to rational targeting of the response remain unknown. Among them, mechanisms underlying the adaptive and maladaptive features of autophagy are obscure. With time and further study, it is possible that this near-ubiquitous cardiac response to stress will emerge as a target for therapeutic manipulation.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Cellular Injury V: Apoptosis and Autophagy
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cardiomyopathy V: Interprofessional Care

